EMEA-000347-PIP02-16-M05
P/0209/2023: EMA decision of 14 June 2023 on the acceptance of a modification of an agreed paediatric investigation plan for bilastine (Bilaxten and associated names), (EMEA-000347-PIP02-16-M05) Reference Number: EMA/236606/2023